AdvaMed Wants More Say In WHO’s Clinical Trial Registry Initiative
This article was originally published in The Gray Sheet
Executive Summary
AdvaMed is pressing to have more of a say in ongoing World Health Organization (WHO) deliberations on a proposed international clinical trial registry, out of concerns that device manufacturers will be forced to publicize product details that could minimize any competitive advantages